Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Phosphatidylcholine transfer protein inhibitor-2
Cat. No.:
OB0425LY-194
Appearance:
Solid
Purity:
98.14%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Phosphatidylcholine transfer protein inhibitor-2 is an inhibitor that specifically targets phosphatidylcholine transfer proteins, which play an important role in lipid metabolism and signaling.
Synonyms:
379712-59-1; Phosphatidylcholine transfer protein inhibitor 2; N-((2-Chloro-5-(N-(3-chlorophenyl)sulfamoyl)phenyl)carbamothioyl)-4-fluorobenzamide; (Z)-2-Chloro-5-[(3-chlorophenyl)sulfamoyl]-N-[(Z)-(4-fluorophenyl)(hydroxy)methylidene]benzene-1-carbamimidothioic acid
CAS No.:
379712-59-1
Compound CID:
4278569
Formula:
C20H14Cl2FN3O3S2
Formula Weight:
498.38
Specification
Target:
Cholinesterase (ChE)
Pathway:
Neuronal signaling
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
Phosphatidylcholine transfer protein inhibitor-2 can be used to explore the association between abnormal lipid metabolism and related diseases.
